Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2023-09-05 | "Dr. Abderrazzak Merzouki" |
| 2023-10-18 | "Dr. Merzouki is a molecular biologist and an immunologist with extensive experience in the area of gene therapy... Dr. Merzouki obtained his Ph.D. in Virology and Immunology from Institut Armand-Frappier in Quebec" |
| 2024-10-17 | "Dr. Merzouki is a molecular biologist and an immunologist with extensive experience in the area of gene therapy... Dr. Merzouki obtained his Ph.D. in Virology and Immunology..." |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-04-09